A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06863961 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06863961
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-07-22
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.